Arrowstreet Capital
NTUS

Arrowstreet Capital’s Natus Medical Inc NTUS Stock Holding History

Arrowstreet Capital’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-223,585
Closed -$7.33M – 1524
2022
Q2 		$7.33M Sell
223,585
-63,178
-22% -$2M 0.01% 545
2022
Q1 		$7.54M Sell
286,763
-113,964
-28% -$2.78M 0.01% 566
2021
Q4 		$9.51M Sell
400,727
-61,474
-13% -$1.52M 0.01% 667
2021
Q3 		$11.6M Sell
462,201
-1,600
-0.3% -$40.8K 0.01% 699
2021
Q2 		$12.1M Sell
463,801
-5,700
-1% -$155K 0.01% 784
2021
Q1 		$12M Hold
469,501
– – 0.02% 794
2020
Q4 		$9.41M Sell
469,501
-3,000
-0.6% -$58.8K 0.01% 904
2020
Q3 		$8.09M Buy
472,501
+130,239
+38% +$2.46M 0.01% 940
2020
Q2 		$7.47M Buy
342,262
+15,200
+5% +$348K 0.01% 889
2020
Q1 		$7.57M Buy
327,062
+95,915
+41% +$2.79M 0.02% 573
2019
Q4 		$7.63M Buy
+231,147
New +$7.41M 0.02% 704
2019
Q3 		– Sell
-120,464
Closed -$3.1M – 1778
2019
Q2 		$3.1M Buy
120,464
+13,600
+13% +$347K 0.01% 788
2019
Q1 		$2.71M Buy
+106,864
New +$3.19M 0.01% 1006
2016
Q3 		– Sell
-5,780
Closed -$218K – 1686
2016
Q2 		$218K Sell
5,780
-16,694
-74% -$559K ﹤0.01% 1262
2016
Q1 		$864K Sell
22,474
-6,306
-22% -$235K ﹤0.01% 1006
2015
Q4 		$1.38M Sell
28,780
-39,219
-58% -$1.82M 0.01% 901
2015
Q3 		$2.68M Buy
67,999
+200
+0.3% +$8.5K 0.01% 679
2015
Q2 		$2.89M Buy
67,799
+40,225
+146% +$1.6M 0.02% 553
2015
Q1 		$1.09M Buy
+27,574
New +$1.02M 0.01% 697

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arrowstreet Capital's NTUS Position: Q3 2022 in Review

Arrowstreet Capital sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 223,585 shares — an estimated $7.33M sold.

Arrowstreet Capital first reported a position in NTUS in Q1 2015 and held it in 19 quarters. The position peaked at $12.1M in Q2 2021. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Arrowstreet Capital reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 223,585 Natus Medical Inc shares in Q3 2022, an estimated $7.33M.
  • Arrowstreet Capital first reported a position in Natus Medical Inc in Q1 2015 and held it in 19 quarters.
  • Arrowstreet Capital's Natus Medical Inc position peaked at $12.1M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Arrowstreet Capital's 13F filing for Q3 2022, filed 14 Nov 2022.